Current Analytical Methods for the Sensitive Assay of New-Generation Ovarian Cancer Drugs in Pharmaceutical and Biological Samples

References

• Lorusso, D.; Ceni, V.; Daniele, G.; Salutari, V.; Pietragalla, A.; Muratore, M.; Nero, C.; Ciccarone, F.; Scambia, G. Newly Diagnosed Ovarian Cancer: Which First-Line Treatment? Cancer Treat Rev. 2020, 91, 102111. DOI: 10.1016/j.ctrv.2020.102111.
   PubMed Web of Science ®Google Scholar
• Orr, B.; Edwards, R. P. Diagnosis and Treatment of Ovarian Cancer. Hematol. Oncol. Clin. North Am. 2018, 32, 943–964. DOI: 10.1016/j.hoc.2018.07.010.
   PubMed Web of Science ®Google Scholar
• Ogundipe, O. D.; Olajubutu, O.; Adesina, S. K. Targeted Drug Conjugate Systems for Ovarian Cancer Chemotherapy. Biomed. Pharmacother. 2023, 165, 115151. DOI: 10.1016/j.biopha.2023.115151.
   PubMed Web of Science ®Google Scholar
• Hennessy, B. T.; Coleman, R. L.; Markman, M. Ovarian Cancer. The Lancet 2009, 374, 1371–1382. DOI: 10.1016/S0140-6736(09)61338-6.
   PubMed Web of Science ®Google Scholar
• Kwolek, D. G.; Gerstberger, S.; Tait, S.; Qiu, J. M. Ovarian, Uterine, and Vulvovaginal Cancers: Screening. Med. Clin. North Am. 2023, 107, 329–355. DOI: 10.1016/j.mcna.2022.10.016.
   PubMed Web of Science ®Google Scholar
• Zheng, F.; Zhang, Y.; Chen, S.; Weng, X.; Rao, Y.; Fang, H. Mechanism and Current Progress of Poly ADP-Ribose Polymerase (PARP) İnhibitors in the Treatment of Ovarian Cancer. Biomed. Pharmacother. 2020, 123, 109661. DOI: 10.1016/j.biopha.2019.109661.
   PubMed Web of Science ®Google Scholar
• Muinao, T.; Deka Boruah, H. P.; Pal, M. Diagnostic and Prognostic Biomarkers in Ovarian Cancer and the Potential Roles of Cancer Stem Cells – An Updated Review. Exp. Cell Res. 2018, 362, 1–10. DOI: 10.1016/j.yexcr.2017.10.018.
   PubMed Web of Science ®Google Scholar
• Zhang, B.; Cai, F. F.; Zhong, X. Y. An Overview of Biomarkers for the Ovarian Cancer Diagnosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 158, 119–123. DOI: 10.1016/j.ejogrb.2011.04.023.
   PubMed Web of Science ®Google Scholar
• Taylor, S. E.; Kirwan, J. M. Ovarian Cancer: Current Management and Future Directions. Obstet. Gynaecol. Reprod. Med. 2012, 22, 33–37. DOI: 10.1016/j.ogrm.2011.11.003.
   Google Scholar
• Cham, S.; Liu, J. F. Present and Future for PARP Inhibitors in Ovarian Cancer. Adv. Oncol. 2021, 1, 139–154. DOI: 10.1016/j.yao.2021.02.012.
   Google Scholar
• Wang, Y.; Liu, L.; Jin, X.; Yu, Y. Efficacy and Safety of Mirvetuximab Soravtansine in Recurrent Ovarian Cancer with FRa Positive Expression: A Systematic Review and Meta-Analysis. Crit. Rev. Oncol. Hematol. 2023, 194, 104230. DOI: 10.1016/j.critrevonc.2023.104230.
   PubMed Web of Science ®Google Scholar
• Wei, Y.; Liang, H.; Liu, S.; Guan, S.; Ma, K.; Guan, Y.; Chen, Y.; Huang, M.; Wang, X.; Lan, C. Development and Validation of a Sensitive LC–MS/MS Method for the Assay of Four PARP İnhibitors in Human Plasma and İts Application in Ovarian Cancer Patients. J. Pharm. Biomed. Anal. 2024, 237, 115758. DOI: 10.1016/j.jpba.2023.115758.
   PubMed Web of Science ®Google Scholar
• Zhou, A.; Yu, J.; Wu, Y.; Xue, H.; Zhong, D.; Diao, X. A Validated LC-MS/MS Method for the Quantification of Bevacizumab in Rat, Cynomolgus Monkey, and Human Serum. J. Pharm. Biomed. Anal. 2023, 235, 115590. DOI: 10.1016/j.jpba.2023.115590.
   PubMed Web of Science ®Google Scholar
• Nalanda, R. B.; Srinivasa Rao, A.; Sankar, D. G. Olaparib Quantification in Human Plasma for Clinical Purposes Using High-Performance Liquid Chromatography with UV Detector. Anal. Chem. Lett. 2019, 9, 526–534. DOI: 10.1080/22297928.2019.1650109.
   Google Scholar
• Muggia, F. M.; Garcia Jimenez, M.; Murthy, P. Platinum Compounds: Their Continued İmpact on Ovarian Cancer Treatment. Inorganica Chim Acta. 2019, 496, 119037. DOI: 10.1016/j.ica.2019.119037.
   Web of Science ®Google Scholar
• Katzung, B.G.; Trevor, A.J. eds. Basic & Clinical Pharmacology, 13th ed.; McGraw-Hill Publishing: New York, 2015.
   Google Scholar
• Fruscella, E.; Gallo, D.; Ferrandina, G.; D'Agostino, G.; Scambia, G. Gemcitabine: Current Role and Future Options in the Treatment of Ovarian Cancer. Crit. Rev. Oncol. Hematol. 2003, 48, 81–88. DOI: 10.1016/S1040-8428(03)00119-7.
   PubMed Web of Science ®Google Scholar
• Zahedi, P.; Yoganathan, R.; Piquette-Miller, M.; Allen, C. Recent Advances in Drug Delivery Strategies for Treatment of Ovarian Cancer. Expert. Opin. Drug Deliv. 2012, 9, 567–583. DOI: 10.1517/17425247.2012.665366.
   PubMed Web of Science ®Google Scholar
• Colombo, N.; Conte, P. F.; Pignata, S.; Raspagliesi, F.; Scambia, G. Bevacizumab in Ovarian Cancer: Focus on Clinical Data and Future Perspectives. Crit. Rev. Oncol. Hematol. 2016, 97, 335–348. DOI: 10.1016/j.critrevonc.2015.08.017.
   PubMed Web of Science ®Google Scholar
• Frederick, P. J.; Straughn, J. M.; Alvarez, R. D.; Buchsbaum, D. J. Preclinical Studies and Clinical Utilization of Monoclonal Antibodies in Epithelial Ovarian Cancer. Gynecol. Oncol. 2009, 113, 384–390. DOI: 10.1016/j.ygyno.2009.01.008.
   PubMed Web of Science ®Google Scholar
• Alvarez Secord, A.; O'Malley, D. M.; Sood, A. K.; Westin, S. N.; Liu, J. F. Rationale for Combination PARP İnhibitor and Antiangiogenic Treatment in Advanced Epithelial Ovarian Cancer: A Review. Gynecol. Oncol. 2021, 162, 482–495. DOI: 10.1016/j.ygyno.2021.05.018.
   PubMed Web of Science ®Google Scholar
• Li, J.; Li, Q.; Zhang, L.; Zhang, S.; Dai, Y. Poly-ADP-Ribose Polymerase (PARP) İnhibitors and Ovarian Function. Biomed. Pharmacother. 2023, 157, 114028. DOI: 10.1016/j.biopha.2022.114028.
   PubMed Web of Science ®Google Scholar
• Adabi, M.; Saber, R.; Faridi-Majidi, R.; Faridbod, F. Performance of Electrodes Synthesized with Polyacrylonitrile-Based Carbon Nanofibers for Application in Electrochemical Sensors and Biosensors. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 48, 673–678. DOI: 10.1016/j.msec.2014.12.051.
   PubMed Web of Science ®Google Scholar
• Zhu, C.; Yang, G.; Li, H.; Du, D.; Lin, Y. Electrochemical Sensors and Biosensors Based on Nanomaterials and Nanostructures. Anal. Chem. 2015, 87, 230–249. DOI: 10.1021/ac5039863.
   PubMed Web of Science ®Google Scholar
• Barani, M.; Bilal, M.; Sabir, F.; Rahdar, A.; Kyzas, G. Z. Nanotechnology in Ovarian Cancer: Diagnosis and Treatment. Life Sci. 2021, 266, 118914. DOI: 10.1016/j.lfs.2020.118914.
   PubMed Web of Science ®Google Scholar
• Vandghanooni, S.; Sanaat, Z.; Barar, J.; Adibkia, K.; Eskandani, M.; Omidi, Y. Recent Advances in Aptamer-Based Nanosystems and Microfluidics Devices for the Detection of Ovarian Cancer Biomarkers. TrAC – Trends Anal. Chem. 2021, 143, 116343. DOI: 10.1016/j.trac.2021.116343.
   Web of Science ®Google Scholar
• Sapountzi, E.; Braiek, M.; Chateaux, J. F.; Jaffrezic-Renault, N.; Lagarde, F. Recent Advances in Electrospun Nanofiber İnterfaces for Biosensing Devices. Sensors (Switzerland). 2017, 17, 1887. DOI: 10.3390/s17081887.
   PubMed Web of Science ®Google Scholar
• Chakravarty, A.; Maiti, S.; Mahanty, S.; De, G. Green Synthesis of Electrospun Porous Carbon Nanofibers from Sucrose and Doping of Ag Nanoparticle with Improved Electrical and Electrochemical Properties. Chem. Select. 2017, 2, 2265–2276. DOI: 10.1002/slct.201601920.
   Google Scholar
• Jayabal, S.; Viswanathan, P.; Ramaraj, R. Reduced Graphene Oxide-Gold Nanorod Composite Material Stabilized in Silicate Sol-Gel Matrix for Nitric Oxide Sensor. RSC Adv. 2014, 4, 33541–33548. DOI: 10.1039/C4RA04859H.
   Google Scholar
• Lai, L.; Chen, L.; Zhan, D.; Sun, L.; Liu, J.; Lim, S. H.; Poh, C. K.; Shen, Z.; Lin, J. One-Step Synthesis of NH2-Graphene from in Situ Graphene-Oxide Reduction and İts İmproved Electrochemical Properties. Carbon N Y. 2011, 49, 3250–3257. DOI: 10.1016/j.carbon.2011.03.051.
   Web of Science ®Google Scholar
• Liu, X.; Wang, D.; Li, Y. Synthesis and Catalytic Properties of Bimetallic Nanomaterials with Various Architectures. Nano Today. 2012, 7, 448–466. DOI: 10.1016/j.nantod.2012.08.003.
   Web of Science ®Google Scholar
• Alizadeh, N.; Hallaj, R.; Salimi, A. A Highly Sensitive Electrochemical İmmunosensor for Hepatitis B Virus Surface Antigen Detection Based on Hemin/G-Quadruplex Horseradish Peroxidase-Mimicking DNAzyme-Signal Amplification. Biosens. Bioelectron. 2017, 94, 184–192. DOI: 10.1016/j.bios.2017.02.039.
   PubMed Web of Science ®Google Scholar
• Jirkovský, I.; Panas, E.; Ahlberg, M.; Halasa, S.; Romani, D. J.; Schiffrin. Single Atom Hot-Spots at Au-Pd Nanoalloys for Electrocatalytic H 2O 2 Production. J. Am. Chem. Soc. 2011, 133, 19432–19441. DOI: 10.1021/ja206477z.
   PubMed Web of Science ®Google Scholar
• Liu, R.; Chen, H. M.; Fang, L. P.; Xu, C.; He, Z.; Lai, Y.; Zhao, H.; Bekana, D.; Liu, J. F. Au@Pd Bimetallic Nanocatalyst for Carbon-Halogen Bond Cleavage: An Old Story with New Insight into How the Activity of Pd is Influenced by Au. Environ. Sci. Technol. 2018, 52, 4244–4255. DOI: 10.1021/acs.est.7b05996.
   PubMed Web of Science ®Google Scholar
• Wang, F.; Li, C.; Sun, L. D.; Wu, H.; Ming, T.; Wang, J.; Yu, J. C.; Yan, C. H. Heteroepitaxial Growth of High-İndex-Faceted Palladium Nanoshells and Their Catalytic Performance. J. Am. Chem. Soc. 2011, 133, 1106–1111. DOI: 10.1021/ja1095733.
   PubMed Web of Science ®Google Scholar
• Kong, L.; Su, M.; Peng, Y.; Hou, L.; Liu, J.; Li, H.; Diao, Z.; Shih, K.; Xiong, Y.; Chen, D. Producing Sawdust Derived Activated Carbon by Co-Calcinations with Limestone for Enhanced Acid Orange II Adsorption. J. Clean Prod. 2017, 168, 22–29. DOI: 10.1016/j.jclepro.2017.09.005.
   Web of Science ®Google Scholar
• Yao, G.; Pei, H.; Li, J.; Zhao, Y.; Zhu, D.; Zhang, Y.; Lin, Y.; Huang, Q.; Fan, C. Clicking DNA to Gold Nanoparticles: Poly-Adenine-Mediated Formation of Monovalent DNA-Gold Nanoparticle Conjugates with Nearly Quantitative Yield. NPG Asia Mater. 2015, 7, e159–e159. DOI: 10.1038/am.2014.131.
   Web of Science ®Google Scholar
• Chen, L.; Chao, J.; Qu, X.; Zhang, H.; Zhu, D.; Su, S.; Aldalbahi, A.; Wang, L.; Pei, H. Probing Cellular Molecules with PolyA-Based Engineered Aptamer Nanobeacon. ACS Appl. Mater. Interf. 2017, 9, 8014–8020. DOI: 10.1021/acsami.6b16764.
   PubMed Web of Science ®Google Scholar
• Baig, N.; Sajid, M.; Saleh, T. A. Recent Trends in Nanomaterial-Modified Electrodes for Electroanalytical Applications. TrAC – Trends Anal. Chem. 2019, 111, 47–61. DOI: 10.1016/j.trac.2018.11.044.
   Web of Science ®Google Scholar
• Tahir, A. A.; Wijayantha, K. G. U.; Saremi-Yarahmadi, S.; Mazhar, M.; McKee, V. Nanostructured α-Fe2O3 Thin Films for Photoelectrochemical Hydrogen Generation. Chem. Mater. 2009, 21, 3763–3772. DOI: 10.1021/cm803510v.
   Web of Science ®Google Scholar
• Ozkan, E.; Cetinkaya, A.; Ozcelikay, G.; Nemutlu, E.; Kır, S.; Ozkan, S. A. Sensitive and Cost-Effective Boron Doped Diamond and Fe2O3/Chitosan Nanocomposite Modified Glassy Carbon Electrodes for the Trace Level Quantification of anti-Diabetic Dapagliflozin Drug. Electroanal. Chem. 2022, 908, 116092. DOI: 10.1016/j.jelechem.2022.116092.
   Google Scholar
• Cetinkaya, A.; Kaya, S. I.; Şenel, P.; Cini, N.; Atici, E. B.; Ozkan, S. A.; Yurtsever, M.; Gölcü, A. Detection of Axitinib Using Multiwalled Carbon Nanotube-Fe2O3/Chitosan Nanocomposite-Based Electrochemical Sensor and Modeling with Density Functional Theory. ACS Omega. 2022, 7, 34495–34505. DOI: 10.1021/acsomega.2c04244.
   PubMedGoogle Scholar
• Erdem, A.; Karadeniz, H.; Mayer, G.; Famulok, M.; Caliskan, A. Electrochemical Sensing of Aptamer-Protein İnteractions Using a Magnetic Particle Assay and Single-Use Sensor Technology. Electroanalysis. 2009, 21, 1278–1284. DOI: 10.1002/elan.200804557.
   Web of Science ®Google Scholar
• Grabowska, I.; Sharma, N.; Vasilescu, A.; Iancu, M.; Badea, G.; Boukherroub, R.; Ogale, S.; Szunerits, S. Electrochemical Aptamer-Based Biosensors for the Detection of Cardiac Biomarkers. ACS Omega. 2018, 3, 12010–12018. DOI: 10.1021/acsomega.8b01558.
   PubMed Web of Science ®Google Scholar
• Majidian, M.; Ozcelikay, G.; Cetinkaya, A.; Unal, M. A.; Nazır, H.; Atici, E. B.; Ozkan, S. A. Nanomaterial-Based Electrochemical Sensing Platform for the Determination of Olaparib. Electrochim. Acta. 2023, 449, 142198. DOI: 10.1016/j.electacta.2023.142198.
   Web of Science ®Google Scholar
• Erk, N.; Vural, Ö.; Bouali, W.; Ayse Genc, A.; Gnanasekaran, L.; Karimi-Maleh, H. Smart and Sensitive Nanomaterial-Based Electrochemical Sensor for the Determination of a Poly (ADP-Ribose) Polymerase (PARP) İnhibitor Anticancer Agent. Environ. Res. 2023, 238, 117082. DOI: 10.1016/j.envres.2023.117082.
   PubMed Web of Science ®Google Scholar
• Yan, Q.; Cao, L.; Dong, H.; Tan, Z.; Liu, Q.; Zhang, W.; Zhao, P.; Li, Y.; Liu, Y.; Dong, Y. Sensitive Amperometric İmmunosensor with İmproved Electrocatalytic Au@Pd Urchin-Shaped Nanostructures for Human Epididymis Specific Protein 4 Antigen Detection. Anal. Chim Acta. 2019, 1069, 117–125. DOI: 10.1016/j.aca.2019.04.023.
   PubMed Web of Science ®Google Scholar
• Farzin, L.; Sadjadi, S.; Shamsipur, M.; Sheibani, S.; Hasan Mousazadeh, M. Employing AgNPs Doped Amidoxime-Modified Polyacrylonitrile (PAN-Oxime) Nanofibers for Target İnduced Strand Displacement-Based Electrochemical Aptasensing of CA125 in Ovarian Cancer Patients. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 97, 679–687. DOI: 10.1016/j.msec.2018.12.108.
   PubMed Web of Science ®Google Scholar
• Mattarozzi, M.; Giannetto, M.; Careri, M. Electrochemical İmmunomagnetic Assay as Biosensing Strategy for Determination of Ovarian Cancer Antigen HE4 in Human Serum. Talanta. 2020, 217, 120991. DOI: 10.1016/j.talanta.2020.120991.
   PubMed Web of Science ®Google Scholar
• Hu, C.; Qin, Z.; Fu, J.; Gao, Q.; Chen, C.; Tan, C. S.; Li, S. Aptamer-Based Carbohydrate Antigen 125 Sensor with Molybdenum Disulfide Functional Hybrid Materials. Anal Biochem. 2023, 675, 115213. DOI: 10.1016/j.ab.2023.115213.
   PubMed Web of Science ®Google Scholar
• Kovarova, A.; Kastrati, G.; Pekarkova, J.; Metelka, R.; Drbohlavova, J.; Bilkova, Z.; Selesovska, R.; Korecka, L. Biosensor with Electrochemically Active Nanocomposites for Signal Amplification and Simultaneous Detection of Three Ovarian Cancer Biomarkers. Electrochim Acta. 2023, 469, 143213. DOI: 10.1016/j.electacta.2023.143213.
   Google Scholar
• Yang, Y.; Yang, X.; Yang, Y.; Yuan, Q. Aptamer-Functionalized Carbon Nanomaterials Electrochemical Sensors for Detecting Cancer Relevant Biomolecules. Carbon N Y. 2018, 129, 380–395. DOI: 10.1016/j.carbon.2017.12.013.
   Web of Science ®Google Scholar
• Elvira, K. S.; Gielen, F.; Tsai, S. S. H.; Nightingale, A. M. Materials and Methods for Droplet Microfluidic Device Fabrication. Lab Chip. 2022, 22, 859–875. DOI: 10.1039/d1lc00836f.
   PubMed Web of Science ®Google Scholar
• Gao, D.; Ma, Z.; Jiang, Y. Recent Advances in Microfluidic Devices for Foodborne Pathogens Detection. TrAC – Trends Anal. Chem. 2022, 157, 116788. DOI: 10.1016/j.trac.2022.116788.
   Web of Science ®Google Scholar
• Dabbagh Moghaddam, F.; Akbarzadeh, I.; Marzbankia, E.; Farid, M.; Khaledi, L.; Reihani, A. H.; Javidfar, M.; Mortazavi, P. Delivery of Melittin-Loaded Niosomes for Breast Cancer Treatment: An İn Vitro and İn Vivo Evaluation of anti-Cancer Effect. Cancer Nano. 2021, 12, 14. DOI: 10.1186/s12645-021-00085-9.
   Web of Science ®Google Scholar
• Bigham, A.; Rahimkhoei, V.; Abasian, P.; Delfi, M.; Naderi, J.; Ghomi, M.; Dabbagh Moghaddam, F.; Waqar, T.; Nuri Ertas, Y.; Sharifi, S.; et al. Advances in Tannic Acid-İncorporated Biomaterials: Infection Treatment, Regenerative Medicine, Cancer Therapy, and Biosensing. Chem. Eng. J. 2022, 432, 134146. DOI: 10.1016/j.cej.2021.134146.
   Web of Science ®Google Scholar
• Menon, I.; Zaroudi, M.; Zhang, Y.; Aisenbrey, E.; Hui, L. Fabrication of Active Targeting Lipid Nanoparticles: Challenges and Perspectives. Mater. Today Adv. 2022, 16, 100299. DOI: 10.1016/j.mtadv.2022.100299.
   Google Scholar
• Saw, P. E.; Hui Cui, G.; Xu, X. Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System. ChemMedChem. 2022, 17, e202100777. DOI: 10.1002/cmdc.202100777.
   PubMed Web of Science ®Google Scholar
• Sharifi, E.; Bigham, A.; Yousefiasl, S.; Trovato, M.; Ghomi, M.; Esmaeili, Y.; Samadi, P.; Zarrabi, A.; Ashrafizadeh, M.; Sharifi, S.; et al. Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation. Adv. Sci. 2022, 9, e2102678. DOI: 10.1002/advs.202102678.
   Web of Science ®Google Scholar
• Zhou, K.; Wang, M.; Zhou, Y.; Sun, M.; Xie, Y.; Yu, D. G. Comparisons of Antibacterial Performances between Electrospun Polymer@Drug Nanohybrids with Drug-Polymer Nanocomposites. Adv. Compos. Hybrid Mater. 2022, 5, 907–919. DOI: 10.1007/s42114-021-00389-9.
   Google Scholar
• Doghish, A. H.; Hashem, A. M.; Shehabeldine, A. A. M.; Sallam, G. S.; El-Sayyad, S.; Salem. Nanocomposite Based on Gold Nanoparticles and Carboxymethyl Cellulose: Synthesis, Characterization, Antimicrobial, and Anticancer Activities. J. Drug Deliv. Sci. Technol. 2022, 77, 103874. DOI: 10.1016/j.jddst.2022.103874.
   Web of Science ®Google Scholar
• Lyu, L.; Liu, J.; Liu, H.; Liu, C.; Lu, Y.; Sun, K.; Fan, R.; Wang, N.; Lu, N.; Guo, Z.; Wujcik, E. K, Key Laboratory for Liquid–Solid Structural Evolution and Processing of Materials, Ministry of Education and School of Materials Science and Engineering, Shandong University, Jinan, Shandong 250061, China. An Overview of Electrically Conductive Polymer Nanocomposites toward Electromagnetic İnterference Shielding. Eng. Sci. 2018, 2, 26–42. DOI: 10.30919/es8d615.
   Google Scholar
• Wang, C. H.; Weng, C. H.; Che, Y. J.; Wang, K.; Bin Lee, G. Cancer Cell-Specific Oligopeptides Selected by an İntegrated Microfluidic System from a Phage Display Library for Ovarian Cancer Diagnosis. Theranostics. 2015, 5, 431–442. DOI: 10.7150/thno.10891.
   PubMed Web of Science ®Google Scholar
• Dabbagh Moghaddam, F.; Dadgar, D.; Esmaeili, Y.; Babolmorad, S.; Ilkhani, E.; Rafiee, M.; Wang, X. D.; Makvandi, P. Microfluidic Platforms in Diagnostic of Ovarian Cancer. Environ. Res. 2023, 237, 117084. DOI: 10.1016/j.envres.2023.117084.
   PubMed Web of Science ®Google Scholar
• Ibrahim, L. I.; Hajal, C.; Offeddu, G. S.; Gillrie, M. R.; Kamm, R. D. Omentum-on-a-Chip: A Multicellular, Vascularized Microfluidic Model of the Human Peritoneum for the Study of Ovarian Cancer Metastases. Biomaterials. 2022, 288, 121728. DOI: 10.1016/j.biomaterials.2022.121728.
   PubMed Web of Science ®Google Scholar
• Flont, M.; Jastrzębska, E.; Brzózka, Z. Synergistic Effect of the Combination Therapy on Ovarian Cancer Cells under Microfluidic Conditions. Anal. Chim. Acta. 2020, 1100, 138–148. DOI: 10.1016/j.aca.2019.11.047.
   PubMed Web of Science ®Google Scholar
• Liu, X.; Shen, J.; Gong, P.; Yu, H. Inclusion of the Tunneling Phase Shift for İnterferometric Particle İmaging for Bubble Sizing. Particuology. 2021, 54, 50–57. DOI: 10.1016/j.partic.2020.05.004.
   Web of Science ®Google Scholar
• Yang, Q.; Lian, Q.; Xu, F. Perspective: Fabrication of İntegrated Organ-on-a-Chip via Bioprinting. Biomicrofluidics. 2017, 11, 031301. DOI: 10.1063/1.4982945.
   PubMed Web of Science ®Google Scholar
• Wang, H. F.; Liu, Y.; Wang, T.; Yang, G.; Zeng, B.; Zhao, C. X. Tumor-Microenvironment-on-a-Chip for Evaluating Nanoparticle-Loaded Macrophages for Drug Delivery. ACS Biomater. Sci. Eng. 2020, 6, 5040–5050. DOI: 10.1021/acsbiomaterials.0c00650.
   PubMed Web of Science ®Google Scholar
• Kwak, C.; Han, W. Towards Size of Scene in Auditory Scene Analysis: A Systematic Review. J. Audiol. Otol. 2020, 24, 1–9. DOI: 10.7874/jao.2019.00248.
   PubMed Web of Science ®Google Scholar
• Knowlton, S.; Onal, S.; Yu, C. H.; Zhao, J. J.; Tasoglu, S. Bioprinting for Cancer Research. Trends Biotechnol. 2015, 33, 504–513. DOI: 10.1016/j.tibtech.2015.06.007.
   PubMed Web of Science ®Google Scholar
• Moroni, L.; Burdick, J. A.; Highley, C.; Lee, S. J.; Morimoto, Y.; Takeuchi, S.; Yoo, J. J. Biofabrication Strategies for 3D in Vitro Models and Regenerative Medicine. Nat. Rev. Mater. 2018, 3, 21–37. DOI: 10.1038/s41578-018-0006-y.
   PubMed Web of Science ®Google Scholar
• Tsai, S. C.; Hung, L. Y.; Bin Lee, G. An İntegrated Microfluidic System for the İsolation and Detection of Ovarian Circulating Tumor Cells Using Cell Selection and Enrichment Methods. Biomicrofluidics. 2017, 11, 034122. DOI: 10.1063/1.4991476.
   PubMedGoogle Scholar
• Liu, W. T.; Bin Lee, W.; Tsai, Y. C.; Chuang, Y. J.; Hsu, K. F.; Bin Lee, G. An Automated Microfluidic System for Selection of Aptamer Probes against Ovarian Cancer Tissues. Biomicrofluidics. 2019, 13, 014114. DOI: 10.1063/1.5085133.
   PubMed Web of Science ®Google Scholar
• Bahavarnia, F.; Saadati, A.; Hassanpour, S.; Hasanzadeh, M.; Shadjou, N.; Hassanzadeh, A. Paper Based İmmunosensing of Ovarian Cancer Tumor Protein CA 125 Using Novel Nano-İnk: A New Platform for Efficient Diagnosis of Cancer and Biomedical Analysis Using Microfluidic Paper-Based Analytical Devices (μPAD). Int. J. Biol. Macromol. 2019, 138, 744–754. DOI: 10.1016/j.ijbiomac.2019.07.109.
   PubMed Web of Science ®Google Scholar
• Kaya, S. I.; Majidian, M.; Ozcelikay-Akyildiz, G.; Cetinkaya, A.; Topal, B. D.; Atici, E. B.; Ozkan, S. A. A Comparative Study of Molecular Imprinting Techniques Used for Fabrication of Electrochemical Sensor of Olaparib. J. Electrochem. Soc. 2023, 170, 096502. DOI: 10.1149/1945-7111/acf620.
   Web of Science ®Google Scholar
• Reinhardt, S.; Zhao, M.; Mnatsakanyan, A.; Xu, L.; Ricklis, R. M.; Chen, A.; Karp, J. E.; Rudek, M. A. A Rapid and Sensitive Method for Determination of Veliparib (ABT-888), in Human Plasma, Bone Marrow Cells and Supernatant by Using LC/MS/MS. J. Pharm. Biomed. Anal. 2010, 52, 122–128. DOI: 10.1016/j.jpba.2009.12.015.
   PubMed Web of Science ®Google Scholar
• Ye, L.; Chen, J.; Long Li, S.; Liang Zhu, Y.; Xie, S.; Du, X. UPLC-MS/MS Method for the Determination of Talazoparib in Rat Plasma and İts Pharmacokinetic Study. J. Pharm. Biomed. Anal. 2020, 177, 112850. DOI: 10.1016/j.jpba.2019.112850.
   PubMed Web of Science ®Google Scholar
• Morosi, L.; Matteo, C.; Ceruti, T.; Giordano, S.; Ponzo, M.; Frapolli, R.; Zucchetti, M.; Davoli, E.; D'incalci, M.; Ubezio, P. Quantitative Determination of Niraparib and Olaparib Tumor Distribution by Mass Spectrometry İmaging. Int. J. Biol. Sci. 2020, 16, 1363–1375. DOI: 10.7150/ijbs.41395.
   PubMed Web of Science ®Google Scholar
• Krens, S. D.; van der Meulen, E.; Jansman, F. G. A.; Burger, D. M.; van Erp, N. P. Quantification of Cobimetinib, Cabozantinib, Dabrafenib, Niraparib, Olaparib, Vemurafenib, Regorafenib and İts Metabolite Regorafenib M2 in Human Plasma by UPLC–MS/MS. Biomed. Chromatogr. 2020, 34, e4758. DOI: 10.1002/bmc.4758.
   PubMed Web of Science ®Google Scholar